RecruitingNCT02693548

The Spanish Familial Hypercholesterolaemia Cohort Study


Sponsor

Fundación Hipercolesterolemia Familiar

Enrollment

4,141 participants

Start Date

Jan 1, 2004

Study Type

OBSERVATIONAL

Conditions

Summary

SAFEHEART is a large, on-going registry study in molecularly defined patients with heterozygous FH treated in Spain.


Eligibility

Min Age: 15 Years

Inclusion Criteria1

  • Index cases with genetic diagnosis of FH and their relatives over 15 years old with a genetic diagnosis of FH and their first-degree relatives

Exclusion Criteria1

  • Patient unwillingness

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fundacion Hipercolesterolemia Familiar

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02693548


Related Trials